Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Cellares and Ori Biotech’s new cell therapy manufacturing contracts

Plus more from Reckitt, Astellas and Hovione. Cellares’ first Asian partnership: The manufacturer has inked a new partnership with Taiwanese company GenomeFrontier Therapeutics, under which Cellares will evaluate manufacturing GenomeFrontier’s CAR-T ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 17 September →